References
- Boyle P, Napakov P. Epidemiology of benign prostatic hyperplasia: current perspectives. Eur Urol 1996;29(Suppl 1):7–11.
- Abrams P. New words for old: lower urinary tract symptoms for "prostatism". Br Med J 1994;308:929–30.
- Abrams P. Evaluating lower urinary tract symptoms sugges-tive of benign prostatic obstruction. Scand J Urol Nephrol Suppl 1999;203:1–7.
- Vesely S, Knutson T, Damber J-E, Diucio M, Dahlstrand C. Relationship between age, prostate volume, prostate-specific antigen, symptom score and uroflowmetry in men with lower urinary tract symptoms. Scand J Urol Nephrol 2003;37: 322–8.
- Boyle P, Gould AL, Roehrborn CG. Prostate volume predicts outcome of treatment of benign prostatic hyperpla-sia with finasteride: meta-analysis of randomized clinical trials. Urology 1996;48:398–404.
- Roehrborn CG, McConnell J, Bonilla J, Rosenblatt S, Hudson PB, Malek GH, et al. Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia. J Urol 2000;163:13 — 20.
- The Finnish Urological society. Recommendations for the care of benign hyperplasia of the prostate gland. Duodecim 1999;115:161–9.
- Richardson TD, Oesterling JE. Age-specific reference ranges for serum prostate-specific antigen. Urol Clin North Am 1997;24:339–51.
- Hedelin H, Johansson N, Stroberg P. Uneven quality of referrals for lower urinary tract symptoms in men. Läkartid-ningen 2003;100:1435–7.
- Lepor H, Machi G. Comparison of the AUA symptom index in unselected males and females between 55 and 79 years of age. Urology 1993;42:36–40.
- Thomas AW, Abrams P. Lower urinary tract symptoms, benign prostatic obstruction and overactive bladder. BJU Int 2000;(Suppl 3):57–68,70-1.
- Nickel JC. Effective office management of chronic prostati-tis. Urol Clin North Am 1998;25:667–84.
- Mehik A, Hellström P, Lukkarinen A, Sarpola A, Järvelin M-R. Epidemiology of prostatitis in Finnish men: a popula-tion based cross-sectional study. BJU Int 2000;86: 443–8.
- Bosch JLHR, Hop WCJ, Kirkels WJ, Schr6der FH. The international prostate symptom score in a community-based sample of men between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume. Br J Urol 1995;75: 622–30.